USD10
AVIR Shares
About Atea PharmaceuticalsAtea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.
USD10
AVIR Shares
About Atea PharmaceuticalsAtea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.
Stats
TRADING WINDOW
Closed
OPENS AT
Not enough data
MARKET CAP
$398.44M
OPEN PRICE
$4.65
LOW (1Y)
$2.78
HIGH (1Y)
$6.45
LOW (24H)
$4.64
HIGH (24H)
$4.90
VOLUME (24H)
$225.63K
7.87%
Price history
Time | Price | Change |
|---|---|---|
Today | $4.65 | |
1 Day | $4.80 | |
1 Week | $4.95 | |
1 Month | $4.28 | |
1 Year | $3.43 |
Past performance is not a reliable indicator of future results.
Discover more
Popular cryptocurrencies
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.